These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Omeprazole and acid peptic disease. Piper DW; Yeomans ND; Shearman DJ Med J Aust; 1991 Mar; 154(6):374-5. PubMed ID: 2000048 [No Abstract] [Full Text] [Related]
3. [Therapeutic achlorhydria: for which diseases, when and for how long?]. Koop H; Arnold R Dtsch Med Wochenschr; 1988 Mar; 113(13):516-8. PubMed ID: 2894969 [No Abstract] [Full Text] [Related]
4. [Omeprazole. Its pharmacology and therapeutic efficacy]. Protzer U; Holtermüller KH Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164 [No Abstract] [Full Text] [Related]
5. Omeprazole: a comprehensive review. Massoomi F; Savage J; Destache CJ Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967 [TBL] [Abstract][Full Text] [Related]
6. Criteria for use of omeprazole in adult inpatients and outpatients. Lajoie C Clin Pharm; 1992 Feb; 11(2):177-9. PubMed ID: 1551300 [No Abstract] [Full Text] [Related]
13. H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases. Lamers CB Digestion; 1989; 44 Suppl 1():92-5. PubMed ID: 2691316 [TBL] [Abstract][Full Text] [Related]
14. Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis. Bium AL Digestion; 1989; 44 Suppl 1():87-91. PubMed ID: 2691314 [TBL] [Abstract][Full Text] [Related]
15. [Strong inhibition of gastric acid secretion: when is it justifiable?]. Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653 [No Abstract] [Full Text] [Related]
16. Clinical experience with omeprazole: assessment of efficacy and safety. Walan A J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359 [TBL] [Abstract][Full Text] [Related]
17. [Lansoprazole--profile of a new proton pump inhibitor]. Seifert E Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467 [TBL] [Abstract][Full Text] [Related]
18. [Indications and use of omeprazole in esophago-gastro-duodenal diseases]. Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238 [No Abstract] [Full Text] [Related]
19. [The present state of knowledge on the treatment of peptic diseases with cimetidine]. Romankiewicz JA; Reidenberg MM Internist (Berl); 1981 Dec; 22(12):762-6. PubMed ID: 6797984 [No Abstract] [Full Text] [Related]
20. [Omeprazole. A new substance for inhibiting acid production]. Uhl D Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691 [No Abstract] [Full Text] [Related] [Next] [New Search]